LeMaitre Vascular Retained Earnings 2011-2026 | LMAT

Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.

Possible uses include

reinvestment in development (R&D, equipment, marketing)
debt repayment
acquisition of other companies
creation of reserves for the future

A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.

The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.

Annual Retained Earnings LeMaitre Vascular

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
185 M	145 M	115 M	97.8 M	88.1 M	70.6 M	57 M	45.8 M	28.3 M	15.3 M	8.16 M	3.25 M	-667 K	-3.87 M	-6.44 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
185 M	-6.44 M	56.6 M

Quarterly Retained Earnings LeMaitre Vascular

2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
174 M	161 M	152 M	138 M	130 M	-	110 M	106 M	101 M	97.8 M	94.9 M	-	91.4 M	88.1 M	84.4 M	80.3 M	74.2 M	70.6 M	70.6 M	70.6 M	70.6 M	57 M	57 M	57 M	57 M	45.8 M	45.8 M	45.8 M	45.8 M	28.3 M	28.3 M	28.3 M	28.3 M	15.3 M	15.3 M	15.3 M	15.3 M	8.16 M	8.16 M	8.16 M	8.16 M	3.25 M	3.25 M	3.25 M	3.25 M	-667 K	-667 K	-667 K	-667 K	-3.87 M	-3.87 M	-3.87 M	-3.87 M	-6.44 M	-6.44 M	-6.44 M	-6.44 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
174 M	-6.44 M	46.4 M

Retained Earnings of other stocks in the Medical instruments industry

Issuer	Retained Earnings	Price	% 24h	Market Cap	Country
The Cooper Companies COO	7.64 B	$ 70.29	0.17 %	$ 14 B	USA
Atrion Corporation ATRI	382 K	-	-	$ 810 M	USA
Luminex Corporation LMNX	83.8 M	-	-	$ 1.75 B	USA
Akers Biosciences, Inc. AKER	-120 M	-	-9.52 %	$ 20.6 M	USA
Alcon ALC	19.4 B	$ 74.63	0.09 %	$ 40.4 B	Schweiz
Antares Pharma, Inc. ATRS	-223 M	-	-	$ 955 M	USA
Cantel Medical Corp. CMD	548 M	-	-1.18 %	$ 3.4 B	USA
CRH Medical Corporation CRHM	-11.9 M	-	-	$ 282 M	USA
Hill-Rom Holdings, Inc. HRC	2.13 B	-	-0.05 %	$ 10.3 B	USA
Baxter International BAX	13.7 B	$ 16.65	-0.18 %	$ 8.54 B	USA
Varian Medical Systems, Inc. VAR	1.13 B	-	-0.02 %	$ 16.3 B	USA
BioLife Solutions BLFS	-335 M	$ 19.27	-1.23 %	$ 888 M	USA
AtriCure ATRC	-413 M	$ 29.19	0.41 %	$ 1.39 B	USA
electroCore ECOR	-191 M	$ 7.04	3.53 %	$ 59.7 K	USA
Ekso Bionics Holdings EKSO	-262 M	$ 9.75	3.72 %	$ 23.7 M	USA
Glaukos Corporation GKOS	-599 M	$ 116.69	3.48 %	$ 5.65 B	USA
Haemonetics Corporation HAE	352 M	$ 58.46	2.87 %	$ 2.94 B	USA
Harvard Bioscience HBIO	-215 M	$ 5.53	6.35 %	$ 245 M	USA
ICU Medical ICUI	691 M	$ 122.99	-0.26 %	$ 3.03 B	USA
InfuSystem Holdings INFU	-59.3 M	$ 9.43	1.51 %	$ 195 M	USA
iRhythm Technologies IRTC	-803 M	$ 117.22	0.36 %	$ 3.75 B	USA
Isoray ISR	-335 M	-	0.03 %	$ 108 M	USA
Intuitive Surgical ISRG	7.01 B	$ 452.58	0.11 %	$ 162 B	USA
Repro Med Systems KRMD	-32 M	$ 4.26	-1.39 %	$ 197 M	USA
Masimo Corporation MASI	1.49 B	$ 178.49	-0.06 %	$ 9.51 B	USA
Microbot Medical MBOT	-104 M	$ 2.36	-1.67 %	$ 108 M	Israel
Milestone Scientific MLSS	-134 M	$ 0.29	1.9 %	$ 23.8 M	USA
Merit Medical Systems MMSI	824 M	$ 67.81	0.16 %	$ 4.01 B	USA
Envista Holdings Corporation NVST	-440 M	$ 25.81	-	$ 4.34 B	USA
Predictive Oncology POAI	-414 M	-	-	$ 31.1 M	USA
Pro-Dex PDEX	35.9 M	$ 48.53	-6.08 %	$ 160 M	USA
Pulse Biosciences PLSE	-463 M	$ 22.94	-0.26 %	$ 1.55 B	USA
ResMed RMD	3.61 B	$ 224.93	0.37 %	$ 32.9 B	USA
Retractable Technologies RVP	13.9 M	$ 0.71	2.98 %	$ 21.3 M	USA
NeuroMetrix NURO	-218 M	-	5.05 %	$ 9.02 M	USA
STAAR Surgical Company STAA	-148 M	$ 20.96	3.71 %	$ 1.04 B	USA
STERIS plc STE	2.48 B	$ 219.97	0.58 %	$ 21.7 B	USA
Stereotaxis STXS	-583 M	$ 1.88	-0.53 %	$ 171 M	USA
Teleflex Incorporated TFX	3.15 B	$ 115.04	-2.35 %	$ 5.13 B	USA
Utah Medical Products UTMD	129 M	$ 62.93	-0.3 %	$ 204 M	USA
West Pharmaceutical Services WST	4.37 B	$ 256.85	0.8 %	$ 18.6 B	USA
DENTSPLY SIRONA XRAY	-1.56 B	$ 11.64	0.09 %	$ 2.32 B	USA
AngioDynamics ANGO	-429 M	$ 9.84	-4.56 %	$ 402 M	USA
Becton, Dickinson and Company BDX	16.6 B	$ 155.32	0.52 %	$ 44.7 B	USA
Nephros NEPH	-144 M	$ 2.86	-0.35 %	$ 29.7 M	USA
OraSure Technologies OSUR	-172 M	$ 3.08	-	$ 226 M	USA
Repligen Corporation RGEN	433 M	$ 116.95	-0.7 %	$ 6.52 M	USA